CD34 and endothelial dysfunction: Saxagliptin, in combination with metformin, can help improve endothelial dysfunction in early diabetes before macrovascular complications appear, and this effect was potentially related to upregulation in CD34+ endothelial progenitor cells for antioxidant SOD1 (Dore et al., 2018).